Jensen, M. and Heinl, A. and Nielsen, S. F. and Palarasah, Y. and Svenningsen, P. and Bech, J. N. and Mose, F. H. and Jensen, B. L. (2025) SGLT-2 inhibitor empagliflozin increases alternative complement activation in patients with diabetes and chronic kidney disease. ACTA PHYSIOLOGICA, 241 (S735). OS 15-06. ISSN 1748-1708, 1748-1716
Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/a...
| Item Type: | Article |
|---|---|
| Subjects: | 500 Science > 570 Life sciences |
| Divisions: | Biology, Preclinical Medicine > Institut für Physiologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 13 Aug 2026 06:11 |
| Last Modified: | 13 Aug 2026 06:11 |
| URI: | https://pred.uni-regensburg.de/id/eprint/67011 |
Actions (login required)
 |
View Item |
